Updates from The Motley Fool

Latest updates on Genetic Technologies Limited (ADR) from Fool.com.


Stock Performance

GENE vs. S&P 500 | 2 Year Performance
GENE 1-Day Stock Chart
GENE 5-Day Stock Chart
GENE 1-Month Stock Chart
GENE 3-Month Stock Chart
GENE 6-Month Stock Chart
GENE 1-Year Stock Chart
GENE 2-Year Stock Chart
GENE 5-Year Stock Chart
View Interactive GENE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Genetic Technologies Limited (ADR).
Current Price: $2.42
Prev Close: $2.44
Open: $2.49
Bid: $2.09
Ask: $2.51
Day's Range: $2.41 - $2.50
52wk Range: $1.62 - $5.05
Volume: 40,303
Avg Vol 129,470
Market Cap: $27.67M
P/E (ttm): -0.92
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Genetic Technologies Limited (ADR).
CAPS Rating 1 out of 5
 
32 Outperform
61 Underperform
CAPS All Stars
 
2 Outperform
32 Underperform

How do you think Genetic Technologies Limited (ADR) will perform against the market?



You pick for Genetic Technologies Limited (ADR) is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Alison Mew, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Genetic Technologies Limited (ADR).

A biotechnology company, pursuing commercial opportunities in: out-licensing its non-coding patents globally; expanding genetic service-testing business in the Asia-Pacific Region; & supporting research projects in which it is already involved.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services